-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
INTEGRATED BIOPHARMA INC quarterly/annual Deferred State and Local Income Tax Expense (Benefit) history and change rate from Q3 2020 to Q3 2025.
- INTEGRATED BIOPHARMA INC Deferred State and Local Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $22K, a 60% decline year-over-year.
- INTEGRATED BIOPHARMA INC Deferred State and Local Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was -$183K, a 473% decline year-over-year.
- INTEGRATED BIOPHARMA INC annual Deferred State and Local Income Tax Expense (Benefit) for 2025 was -$150K, a 15100% decline from 2024.
- INTEGRATED BIOPHARMA INC annual Deferred State and Local Income Tax Expense (Benefit) for 2024 was $1K, a 94.4% decline from 2023.
Deferred State and Local Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred State and Local Income Tax Expense (Benefit), Quarterly (USD)
Deferred State and Local Income Tax Expense (Benefit), YoY Quarterly Change (%)
Deferred State and Local Income Tax Expense (Benefit), Annual (USD)
Deferred State and Local Income Tax Expense (Benefit), YoY Annual Change (%)